Scinai Immunotherapeutics Ltd.

Ownership Transactions Reported by 12 Insiders

Symbol
SCNI on Nasdaq
Location
Jerusalem Biopark, 2 Nd Floor, Hadassah Ein Kerem Campus, Jerusalem, Israel

There are no Buy or Sell transactions made by insiders since 9/12/2023

Scinai Immunotherapeutics Ltd. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Samuel Moed Director Jan 1, 2023
George Lowell Director Jan 1, 2023
Morris Laster Director Jan 1, 2023
Yael Margolin Director Jan 1, 2023
Adi Raviv Director Jan 1, 2023
Elad Mark Chief Operating Officer Jan 1, 2023
Jay Green Director Jan 1, 2023
Mark Germain Director, Chairman Jan 1, 2023
Avner Rotman Director Jan 1, 2023
Amir Reichman Chief Executive Officer, Director Jan 1, 2023
Tamar Ben-Yedidia Chief Scientist Jan 1, 2023
Uri Ben-Or Chief Financial Officer Jan 1, 2023

There are no transactions filed by insiders of Scinai Immunotherapeutics Ltd.